Article Text
Abstract
Paraneoplastic demyelination is a rare disorder of the central nervous system. We describe a 60-year-old man with tumefactive demyelination who had an underlying retroperitoneal germ cell cancer. He presented with visuospatial problems and memory loss and had a visual field defect. His MRI was interpreted as a glioma but stereotactic biopsy showed active demyelination. Investigation for multiple sclerosis was negative but CT imaging showed retroperitoneal lymphadenopathy, and nodal biopsy confirmed a combined germ cell cancer. He responded poorly to corticosteroid treatment, and his visual field defect progressed. However, 6 months after plasma exchange and successful chemotherapy, he has partially improved clinically and radiographically. Tumefactive demyelination is typically associated with multiple sclerosis but may be paraneoplastic. It is important to recognise paraneoplastic tumefactive demyelination early, as the neurological outcome relies on treating the associated malignancy.
- germ cell cancer
- seminoma
- paraneoplastic syndromes, nervous system
- demyelination
- tumefactive
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Tumefactive demyelination: an approach to diagnosis and management
- The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases
- Rhomboencephalitis
- A practical review of the neuropathology and neuroimaging of multiple sclerosis
- Tumefactive demyelination associated with systemic lupus erythematosus
- Prognostication and contemporary management of clinically isolated syndrome
- Imaging in multiple sclerosis and related disorders
- Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange
- Imaging in multiple sclerosis
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron